SE8501614L - Solubiliserbar, fibrinbaserad komposition och anvendning derav - Google Patents

Solubiliserbar, fibrinbaserad komposition och anvendning derav

Info

Publication number
SE8501614L
SE8501614L SE8501614A SE8501614A SE8501614L SE 8501614 L SE8501614 L SE 8501614L SE 8501614 A SE8501614 A SE 8501614A SE 8501614 A SE8501614 A SE 8501614A SE 8501614 L SE8501614 L SE 8501614L
Authority
SE
Sweden
Prior art keywords
fibrin
composition
pct
desaa
arginyl
Prior art date
Application number
SE8501614A
Other languages
English (en)
Other versions
SE8501614D0 (sv
SE447579B (sv
Inventor
M G Ranby
Original Assignee
Biopool Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20359734&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE8501614(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biopool Ab filed Critical Biopool Ab
Priority to SE8501614A priority Critical patent/SE447579B/sv
Publication of SE8501614D0 publication Critical patent/SE8501614D0/sv
Priority to PCT/SE1986/000144 priority patent/WO1986005814A1/en
Priority to EP86902552A priority patent/EP0216891B1/en
Priority to AT86902552T priority patent/ATE50002T1/de
Priority to DE8686902552T priority patent/DE3668643D1/de
Priority to US06/936,347 priority patent/US4957903A/en
Publication of SE8501614L publication Critical patent/SE8501614L/sv
Publication of SE447579B publication Critical patent/SE447579B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/75—Fibrin; Fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/972—Plasminogen activators
    • G01N2333/9726—Tissue plasminogen activator
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SE8501614A 1985-04-01 1985-04-01 Solubiliserbar, fibrinbaserad komposition och anvendning av kompositionen vid bestemning av fibrinolysparametrar SE447579B (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE8501614A SE447579B (sv) 1985-04-01 1985-04-01 Solubiliserbar, fibrinbaserad komposition och anvendning av kompositionen vid bestemning av fibrinolysparametrar
PCT/SE1986/000144 WO1986005814A1 (en) 1985-04-01 1986-03-27 A solubilizable, fibrin based composition and its use, in determinations of fibrinolysis parameters
EP86902552A EP0216891B1 (en) 1985-04-01 1986-03-27 A solubilizable, fibrin based composition and its use
AT86902552T ATE50002T1 (de) 1985-04-01 1986-03-27 Loesbare auf fibrin basierte zusammensetzung und deren verwendung.
DE8686902552T DE3668643D1 (de) 1985-04-01 1986-03-27 Loesbare auf fibrin basierte zusammensetzung und deren verwendung.
US06/936,347 US4957903A (en) 1985-04-01 1986-03-27 Pharmaceutical and clinical compositions of desAA fibrin monomers and the tetrapeptide gly-pro-arg-pro

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8501614A SE447579B (sv) 1985-04-01 1985-04-01 Solubiliserbar, fibrinbaserad komposition och anvendning av kompositionen vid bestemning av fibrinolysparametrar

Publications (3)

Publication Number Publication Date
SE8501614D0 SE8501614D0 (sv) 1985-04-01
SE8501614L true SE8501614L (sv) 1986-10-02
SE447579B SE447579B (sv) 1986-11-24

Family

ID=20359734

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8501614A SE447579B (sv) 1985-04-01 1985-04-01 Solubiliserbar, fibrinbaserad komposition och anvendning av kompositionen vid bestemning av fibrinolysparametrar

Country Status (5)

Country Link
US (1) US4957903A (sv)
EP (1) EP0216891B1 (sv)
DE (1) DE3668643D1 (sv)
SE (1) SE447579B (sv)
WO (1) WO1986005814A1 (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2710376B2 (ja) * 1987-07-06 1998-02-10 サイトアールエックス バイオプール リミテッド 組織プラズミノーゲン活性因子とプラズミノーゲン活性因子阻害因子の改良された評価方法
US5102787A (en) * 1987-07-10 1992-04-07 Miho Sasamata Method, device and kit for measurement of tissue plasminogen activator activity
US5320945A (en) * 1989-07-14 1994-06-14 Boehringer Mannheim Gmbh Method and reagent for the determination of antithrombin III
AU644205B2 (en) * 1990-08-23 1993-12-02 New York Blood Center, Inc., The Assays using a soluble fibrin-like monomer
EP0641222B1 (en) * 1992-05-21 2000-09-06 Diatide, Inc. TECHNETIUM-99m LABELED PEPTIDES FOR THROMBUS IMAGING
US5968476A (en) * 1992-05-21 1999-10-19 Diatide, Inc. Technetium-99m labeled peptides for thrombus imaging
CN1091315A (zh) * 1992-10-08 1994-08-31 E·R·斯奎布父子公司 血纤维蛋白封闭剂组合物及其使用方法
AU6398596A (en) * 1995-06-30 1997-02-05 American Biogenetic Sciences, Inc. Method of producing fibrin-specific antibodies using soluble fibrin polymers as an immunogen
AU7353300A (en) 1999-09-08 2001-04-10 Guilford Pharmaceuticals Inc. Non-peptidic cyclophilin binding compounds and their use
FR2813395B1 (fr) * 2000-08-28 2003-01-24 Stago Diagnostica Methode de dosage in vitro de la fibrine soluble par generation de produits de degradation specifiques
MXPA03006666A (es) 2001-01-25 2004-05-31 Guilford Pharm Inc Compuestos de union de ciclofilina carbociclicos trisubstituidos y su uso.
US6593362B2 (en) 2001-05-21 2003-07-15 Guilford Pharmaceuticals Inc. Non-peptidic cyclophilin binding compounds and their use
RU2358754C2 (ru) 2004-06-24 2009-06-20 Тобиси Фармасьютикал Ко., Лтд. Препарат, ингибирующий развитие злокачественных опухолей, содержащий дез-а-фибрин

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966701A (en) * 1973-11-07 1976-06-29 The Dow Chemical Company Fibrinogen peptide derivatives
US4455290A (en) * 1981-04-02 1984-06-19 Research Corporation Inhibition of fibrin polymerization by a peptide isolated from fibrin Fragment D1

Also Published As

Publication number Publication date
WO1986005814A1 (en) 1986-10-09
EP0216891A1 (en) 1987-04-08
SE8501614D0 (sv) 1985-04-01
DE3668643D1 (de) 1990-03-08
US4957903A (en) 1990-09-18
EP0216891B1 (en) 1990-01-31
SE447579B (sv) 1986-11-24

Similar Documents

Publication Publication Date Title
SE8501614D0 (sv) Solubiliserbar, fibrinbaserad komposition och anvendning derav
van Sande et al. Distribution of angiotensin converting enzyme in human tissues
DE69903898D1 (de) Teststreifen zur visuellen Ermittlung der Blutglukose-Konzentration
ATE275583T1 (de) KALLIKREINHEMMENDE ßKUNITZ-DOMÄNEß-PROTEINE UND DERIVATEN DAVON
NO922149D0 (no) Fremgangsmaater for paavisning av collagen-nedbrytning in vivo
BR9508151A (pt) Oligopeptídeo testes para determinar a atividade proteolítica de antígeno livre específico para próstata em uma amostra e para identificar compostos que inibem atividade proteolítica de antígeno específico para próstata e conjugado
CA2366682A1 (en) Tissue inhibitor of matrix metalloproteinases type-1 (timp-1) as a cancer marker
ATE223051T1 (de) Verfahren zur diagnose gutartiger prostataerkrankungen
ES8607262A1 (es) Esteres de aminoacidos y de peptidos cromogenos
DE60032784D1 (de) Markerproteine für prostatakrebs
GB1533205A (en) Plasmin fractions and complexes thereof
Walsh et al. Neuropeptide degrading enzymes in normal and inflamed human synovium.
ATE216495T1 (de) Diagnostisches verfahren für atherosklerosis
ATE24917T1 (de) Peptide-derivate, deren herstellung und verwendung als elastasehemmende mittel.
DK0931265T3 (da) Diagnistisk metode for aterosklerose
Zacharski et al. Cellular localization of activated factor X by Xa-specific probes
ES2159324T3 (es) Ensayo.
DE68911574D1 (de) Reagenzsystem zur Bestimmung des Komplexes des menschlichen Plasminogenaktivator-Inhibitors und des menschlichen Gewebeplasminogenaktivators und Testsatz dafür.
Yoshida et al. A novel function of extraerythrocytic hemoglobin
Grant et al. Catalytically active enterokinase in human bile
Vahtera et al. Absence of binding of pancreatic and urinary kallikreins to α 2-macroglobulin
Furihata et al. A new fluorescent microassay method for pepsin using succinyl-albumin
Hiroyuki et al. Studies on kallikrein-kinin system in plasma of patients with acute pancreatitis
WILL et al. Expression of urokinase-type plasminogen-activator (uPA) and Its receptor (uPAR) in human ovarian-cancer cells and in-vitro invasion capacity
Molnar et al. Enzymatic modifications of human plasma fibronectin in relation to opsonizing activity

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8501614-5

Effective date: 19911108

Format of ref document f/p: F